0913693 BC Ltd REPCF
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.02 / $0.10
- Shares Outstanding
- 73.58M
- Market Cap
- $7,357.78
- Volume/Avg
- 118,998 / 60,227
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
0913693 BC Ltd is a regenerative medicine company focused on aesthetics and orthopedics. It is a royalty company that holds its primary royalty assets focused on autologous cell therapies that treat functional cellular deficits, including chronic tendon injuries, androgenetic alopecia, and skin aging. The Company is organized into one business unit based on its cell replication technology and has one reportable operating segment. Its product line is RCT-01 Tendon Repair, RCS-01 Skin Rejuvenation, RCH-01 Hair Growth, and DermaPrecise.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 0
- Website
- https://www.replicel.com
Valuation
|
Metric
|
REPCF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
REPCF
|
|---|---|
Quick Ratio | 0.09 |
Current Ratio | 0.13 |
Interest Coverage | −37.83 |
Quick Ratio
REPCF
Profitability
|
Metric
|
REPCF
|
|---|---|
Return on Assets (Normalized) | 81.81% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
REPCF
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|!cLgXd^ | LOCK|%TGqP | $128B | |||
| Moderna Inc
MRNA
| LOCK|S#&&cs | LOCK|ZR? | $76B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|@PKtfKM | LOCK|!Kqn | $76B | |||
| argenx SE ADR
ARGX
| LOCK|#!ss@zs | LOCK|dS | $57B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|%Zd?xs | LOCK|!mT | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|VlB%!# | LOCK|@&KLy | $29B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|$!t>mRK | LOCK|xg%#G | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|>ggB!t | LOCK|?H | $24B | |||
| Incyte Corp
INCY
| LOCK|@Jj%&ZC | LOCK|<n@ | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|@Lfv>l% | LOCK|LzQ | $15B |
United States